A Prospective, Multicenter Observational Study on MAST™ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
NCT ID: NCT01143324
Last Updated: 2019-01-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
255 participants
OBSERVATIONAL
2010-06-30
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures to Treat Degenerative Lumbar Spine (MASTERS-D2)
NCT02617563
Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease
NCT01195584
Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease. A Prospective Long-term Evaluation
NCT01259960
Minuteman Spinal Fusion Implant Versus Surgical Decompression for Lumbar Spinal Stenosis
NCT01455805
A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF
NCT01640977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The minimally invasive spinal surgery was developed as a potential solution to the above-mentioned problems by reducing the amount of iatrogenic soft tissue injury while reaching the same traditional goals of the open procedures. Besides minimizing the long-term effects of exposure-related muscle injury, minimally invasive lumbar fusion techniques hold the promise of immediate short-term advantages. Patients undergoing minimally invasive procedures are reported to recover earlier from the surgery. Shorter time to first ambulation, less pain medication consumption, less blood loss, less required transfusion, shorter hospital stay and earlier return to work are generally associated with the minimally invasive procedure as compared to the standard open surgeries. The minimally invasive access requires a surgical corridor targeted on the disease which is accomplished by using a series of tubular muscle dilators allowing a clear intraoperative visualization to perform these procedures together with the parallel use of image guided percutaneous insertion of pedicle screws and instrumentation.
The purpose of this study is to observe and document surgical practice and evaluate patients' outcomes following a MAST™ single or double level instrumented fusion procedure using PLIF or TLIF techniques for the treatment of the degenerative lumbar spine in a "real-world" patient population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAST™ procedure
MAST™ procedure
Single or double level instrumented fusion receiving the CD Horizon® Spinal System using PLIF or TLIF techniques via a MAST™ procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MAST™ procedure
Single or double level instrumented fusion receiving the CD Horizon® Spinal System using PLIF or TLIF techniques via a MAST™ procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has indication for a single or double level instrumented lumbar fusion for the treatment of the degenerative lumbar spine.
* Patient agrees to participate in the study and is able to sign the Data Release Form/Informed Consent.
* The procedure planned for the patient complies with the labeling of the Devices that may be used in the surgical procedure as described in the section B.2 Device Information.
* Patient is planned to be submitted to the fusion procedure using PLIF or TLIF techniques and to receive a CD HORIZON® Spinal System via a MAST™ approach.
* The patient is willing and is able to cooperate with study procedures and required follow-up visits.
Exclusion Criteria
* Indications for the procedure other than degenerative spine disease like Osteoporotic vertebral fractures, Spine trauma fractures and Spine tumor.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Spinal and Biologics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jörg Franke, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
Klinik für Wirbelsäulenchirurgie; Dortmund
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Amstetten
Amstetten, , Austria
OLV Ziekenhuis
Aalst, , Belgium
Spine, Sports Medicine and Orthopedic Surgery
Saint John, New Brunswick, Canada
Karvinska Hornicka Nemocnice
Fryštát, , Czechia
Klinikum Kulmbach
Kulmbach, Bavaria, Germany
Marienhaus Klinikum
Bendorf, , Germany
Neurochirurgische Universitatsklinik
Freiburg im Breisgau, , Germany
Universitätsklinikum Magdeburg
Magdeburg, , Germany
Mediterraneo
Glyfada, , Greece
The Tel Aviv Sourasky Medical Center
Tel Aviv, , Israel
Instituto Ortopedici Rizzoli
Bologna, , Italy
Fatebenefratelli Hospital
Milan, , Italy
Bergman Clinics
Naarden, , Netherlands
Franciscus Ziekenhuis Roosendaal
Roosendaal, , Netherlands
University Clinical Center
Gdansk, , Poland
Hospital San Joao
Porto, , Portugal
Ustredna Vojenska Nemocnica SNP
Ružomberok, , Slovakia
Hospital Clinic De Barcelona
Barcelona, , Spain
Guys & St; Thomas NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MASTERS-D Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.